Skip to main content
. 2021 Feb 26;142(7):1459–1467. doi: 10.1007/s00402-021-03824-0

Table 1.

Patient characteristics and treatment aspects per implant type

Characteristic DHS
N = 32 (25.4%)
PFNA
N = 94 (74.6%)
P value
Patient characteristic
Mean age (years, SD) 81.3 (8.2) 80.9 (18) 0.97
Sex (f) 23 (71.9) 72 (75.8) 0.59
ASA classification
 I–II 16 (50.0) 36 (38.3)
 III–IV 16 (50.0) 58 (61.7) 0.25
Cognitive impairment 6 (18.8) 37 (40.2) 0.028
Activities in daily living
 Independent 27 (87.1) 62 (67.4)
 Dependent 4 (12.9) 30 (32.6) 0.034
Mobility
 Independent 19 (61.3) 37 (39.4)
 With walking aid 11 (35.5) 38 (40.4)
 No independent mobility 1 (3.2) 19 (20.2) 0.033
Living situation
 Home or residential home 30 (93.8) 77 (81.9)
 Nursing home 2 (6.3) 17 (18.1) 0.15*
Treatment aspects
Time to surgery (h, SD) 21.3 (14.8) 24.8 (23.8) 0.44
Surgeons experience
 Resident 21 (65.6) 61 (64.9)
 Surgeon 11 (34.4) 33 (35.1) 0.94
Operation time (min, IQR) 47 (21) 43 (27) 0.020
Surgical blood loss (ml, SD) 100.8 (67.4) 140.2 (108.9) 0.15
TAD > 25 mm 1 (3.3) 3 (3.3) 1.00*
Reduction
 Perfect 6 (22.2) 23 (25.3)
 Acceptable 12 (44.4) 40 (44.0)
 Poor 9 (33.3) 28 (30.8) 0.94

SD standard deviation, IQR interquartile range, f female, ASA American Society of Anaesthesiologists, min minutes, ml millilitre, Italics indicate statistical significance (p < 0.05), TAD tip-apex distance, mm millimetre, *Fisher’s exact test